Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?

Colin Berry; Damien Collison; Kenneth Mangion

doi:10.1016/j.jcin.2019.02.040

Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?

JACC Cardiovasc Interv. 2019 Apr 22;12(8):731-733. doi: 10.1016/j.jcin.2019.02.040.

Authors

Colin Berry¹, Damien Collison², Kenneth Mangion²

Affiliations

¹ British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; Golden Jubilee National Hospital, Clydebank, United Kingdom. Electronic address: colin.berry@glasgow.ac.uk.
² British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; Golden Jubilee National Hospital, Clydebank, United Kingdom.

PMID: 31000011
DOI: 10.1016/j.jcin.2019.02.040

No abstract available

Keywords: ST-segment elevation myocardial infarction; fractional flow reserve; multivessel disease; percutaneous coronary intervention; remodeling.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Coronary Artery Disease*
Humans
Magnetic Resonance Spectroscopy
ST Elevation Myocardial Infarction*
Treatment Outcome

Publication types

MeSH terms

Grants and funding